First Page | Document Content | |
---|---|---|
Date: 2012-10-03 12:53:27Food and Drug Administration Clinical research Thiophenes Healthcare quality Medical terminology Adverse Event Reporting System Duloxetine Pharmacovigilance Rivaroxaban Adverse effect Adverse event MedWatch | QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1Add to Reading ListSource URL: www.ismp.orgDownload Document from Source WebsiteFile Size: 406,52 KBShare Document on Facebook |